Figure 3.
Computed tomography scans of the present non-small cell lung cancer patient. (A) Prior to treatment with gefitinib, (B) stable disease and (C) disease progression following long-term treatment with gefitinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.